• Image for 3 things I want the Black community to know about scientists like me
  • Image for How we kept clinical trials on track amid COVID-19
  • Image for Breaking down barriers, with a little help from man’s best friend
Next story:
Responsibility 20th grant added to initiative to improve maternal health equity across the U.S.

Learn more

Our people 3 things I want the Black community to know about scientists like me

Meet Denarra

Innovation How we kept clinical trials on track amid COVID-19

Learn more

Our people Breaking down barriers, with a little help from man’s best friend

Meet Darley and Clark

Next
  • Image for 3 things I want the Black community to know about scientists like me
  • Image for How we kept clinical trials on track amid COVID-19
  • Image for Breaking down barriers, with a little help from man’s best friend

We invent for life

We’re following the science to tackle some of the world’s greatest health threats. But don’t take it from us – see what our people and patients say.

Image for Your questions answered: How Merck is responding to the COVID-19 pandemic
Responsibility

Your questions answered: How Merck is responding to the COVID-19 pandemic

Image for Women in science? Absolutely.
Our people

Women in science? Absolutely.

Strong career paths and cutting-edge science draw more women to our small molecule process R&D team
young blonde girl with mom in doctors office
Patients & caregivers

How can we support you?

Medical treatment can be stressful enough. If you can’t afford your prescribed medications, we may be able to help you.

Research & products

Where creativity meets research

We bring creative minds together to invent important medicines and vaccines. We stop at nothing to help save and improve lives.

Column one image
Corporate responsibility

Supporting the future of our business and the well-being of patients, people and communities around the world.

Column one image
Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.